Shockwave Medical (SWAV) Tops Q3 EPS by 39c, Raises FY Revenue Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. AMGN
3. BKNG
4. DOX
5. DUOL
6. ANET
7. XYZ
8. SPY
9. SWKS
10. FISV

Go back to Shockwave Medical (SWAV) Tops Q3 EPS by 39c, Raises FY Revenue Outlook

Shockwave Medical Reports Third Quarter 2022 Financial Results

November 7, 2022 4:03 PM EST

SANTA CLARA, Calif., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, today reported financial results for the three months ended September 30, 2022.

Recent Highlights

Recognized revenue of $131.3 million for the third quarter of 2022, representing an increase of 102% from the same period in 2021Received FDA Clearance for the Shockwave IVL System with the Shockwave L6 Peripheral IVL CatheterReceived CE marking for the Shockwave... More